MannKind | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Adma Biologics USD 23K 0 2023-12
Dynavax Technologies USD 130K 1000 2023-12
Eli Lilly USD 593.6M 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Insmed USD 1.48M 50K 2023-12
MannKind USD 2.7M 5K 2023-12
Merck USD 1.79B 0 2023-09
Novo Nordisk DKK 451M 0 2023-09
Pfizer USD 478M 0 2023-09
Xencor USD 611K 4K 2023-12



MannKind Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.